Shi, L, Westwood, S, Baird, AL, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, NJ, Morgan, AR, Bos, I, Vos, SJB, Buckley, NJ
, Kate, MT, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, de Roeck, EE, Sleegers, K, Frisoni, GB, Blin, O, Richardson, JC, Bordet, RG, Molinuevo, JL, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P
, Teunissen, CE, Freund-Levi, Y, Frölich, L, Legido-Quigley, C
, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, BP, Streffer, J
, Visser, PJ, Bertram, L, Lovestone, S & Nevado-Holgado, AJ 2019, '
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay',
Alzheimer's and Dementia, vol. 15, no. 11, pp. 1478-1488.
https://doi.org/10.1016/j.jalz.2019.06.4951